RBPJ and Adams-Oliver syndrome: Consistent with the first possibility, humans with homozygous mutations in EOGT[59], or autosomal dominant mutations in RBPJ (CSL homologue of Su(H)) [60]), a downstream effector of Notch signaling, have been shown to cause Adams-Oliver Syndrome, a developmental disease with limb abnormalities and skin defects.